ZYUS — Zyus Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$53.05m
- CA$65.49m
- CA$0.48m
Annual cashflow statement for Zyus Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.728 | 0.351 | -24.7 | -42.6 | -33.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.678 | -0.476 | 8.59 | 32.4 | 21.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.029 | -0.207 | 2.5 | -5.04 | 1.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.022 | -0.333 | -9.57 | -18 | -9.88 |
| Capital Expenditures | — | — | -0.56 | -0.281 | -0.046 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.673 | -0.579 | -0.032 | 4.92 | 1.87 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.673 | -0.579 | -0.592 | 4.64 | 1.83 |
| Financing Cash Flow Items | — | — | — | 18.4 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | — | 9.63 | 17.1 | 5.97 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.652 | -0.913 | -0.538 | 3.77 | -2.08 |